Renal Cell Carcinoma New Reference: Nivolumab and Cabozantinib for Advanced RCC Ulas D. Bayraktar, MD 2022-09-20
Nervous System Tumor Thyroid Cancer New Indication: Dabrafenib and Trametinib in bRAV V600E Mutant Anaplastic Thyroid Cancer Ulas D. Bayraktar, MD 2022-09-20
Gastrointestinal Stromal Tumor New Drug: Ripretinib for Advanced GIST Ulas D. Bayraktar, MD 2022-09-20
Non-Small Cell Lung Cancer New Indication: Neoadjuvant Nivolumab for NSCLC Ulas D. Bayraktar, MD 2022-09-20
GastroEsophageal Cancer New Protocol: Perioperative FLOT with Trastuzumab and Pertuzumab for her2-Positive Gastroesophageal Cancer Ulas D. Bayraktar, MD 2022-07-16
Acute myeloid leukemia New Protocol: Venetoclax with 3 + 7 Chemotherapy for AML Ulas D. Bayraktar, MD 2022-07-16
Colorectal Cancer New Indication: Pembrolizumab for MSI-High Colorectal Cancer Ulas D. Bayraktar, MD 2022-07-16
Soft Tissue Sarcoma New Indication: Selinexor for Advanced Dedifferentiated Liposarcoma Ulas D. Bayraktar, MD 2022-05-20
